(Q38000164)

26 August 2017

title

Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control (English)

1 reference

26 August 2017

Akitada Ichinose

1

1 reference

26 August 2017

language of work or name

1 reference

5 April 2012

1 reference

International Journal of Hematology

26 August 2017

published in

1 reference

26 August 2017

volume

95

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

362-370

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-012-1064-3

26 August 2017

exact match

0 references

cites work

Blood coagulation factor XIII: structure and function

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Impaired clot retraction in factor XIII A subunit-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Ultrastructure of clots during isometric contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Development of platelet contractile force as a research and clinical measure of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

AMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

New insights into the expression and role of platelet factor XIII-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Pathogen entrapment by transglutaminase--a conserved early innate immune mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Sadaaki Iwanaga: Discovery of the lipopolysaccharide- and beta-1,3-D-glucan-mediated proteolytic cascade and unique proteins in invertebrate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

The Sushi peptides: structural characterization and mode of action against Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Management of acquired haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

A familial factor XIII subunit B deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1064-3

Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency

21 January 2018

1 reference

12 December 2020

Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII

1 reference

12 December 2020

Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release

1 reference

12 December 2020

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

1 reference

12 December 2020

Physiopathology and regulation of factor XIII

1 reference

12 December 2020

Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions

1 reference

12 December 2020

Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages

1 reference

12 December 2020

Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit

1 reference

12 December 2020

Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies

1 reference

12 December 2020

A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency

1 reference

12 December 2020

Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency

1 reference

12 December 2020

A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain

1 reference

12 December 2020

Binding of plasma factor XIII to thrombin-receptor activated human platelets.

1 reference

12 December 2020

Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain

1 reference

12 December 2020

Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages

1 reference

12 December 2020

Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII.

1 reference

12 December 2020

10.1007/S12185-012-1064-3

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1044310115

0 references

1 reference